Skip to main content

PSMA/FOLH1/NAALADase I Antibody (CL9089)

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88924

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88924

Key Product Details

Validated by

Orthogonal Validation

Species Reactivity

Validated:

Human

Predicted:

Rat (90%). Backed by our 100% Guarantee.

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # CL9089

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

This antibody was developed against a recombinant protein corresponding to amino acids: ADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNF

Epitope

ADYFAPGVKSYPDGW

Reactivity Notes

Immunogen displays the following percentage of sequence identity for non-tested species: Mouse (86%)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Scientific Data Images for PSMA/FOLH1/NAALADase I Antibody (CL9089)

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924] - Staining of human prostate cancer shows strong cytoplasmic positivity in glandular cells.
Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924] - Staining of human duodenum shows strong membranous positivity in glandular cells.
Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924]

Immunohistochemistry-Paraffin: PSMA/FOLH1/NAALADase I Antibody (CL9089) [NBP2-88924] - Staining of human liver shows weak membranous positivity in hepatocytes.

Applications for PSMA/FOLH1/NAALADase I Antibody (CL9089)

Application
Recommended Usage

Immunohistochemistry

1:50 - 1:200

Immunohistochemistry-Paraffin

1:50 - 1:200
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS, pH 7.2, containing 40% glycerol

Preservative

0.02% Sodium Azide

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: PSMA/FOLH1/NAALADase I

PSMA, also known as Glutamate carboxypeptidase 2, is a 84kDa 750 amino acid protein that has 8 isoforms produced by alternative splicing. The primary function of this protein is to act as a glutamate carboxypeptidase. Current research on PSMA is being conducted in relation to prostate cancer, muscular atrophy, small cell carcinoma, coronary heart disease and Huntington's disease. PSMA is known to interact with MME, MTAP and RPS3.

Long Name

Prostate-specific Membrane Antigen

Alternate Names

FGCP, FOLH1, GCP2, GCPII, mopsm, NAALAD1, NAALADase I

Gene Symbol

FOLH1

Additional PSMA/FOLH1/NAALADase I Products

Product Documents for PSMA/FOLH1/NAALADase I Antibody (CL9089)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for PSMA/FOLH1/NAALADase I Antibody (CL9089)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...